期刊文献+

不同剂量卡维地络干预对压力超负荷幼鼠心肌细胞凋亡和凋亡相关基因表达的影响

Effects of carvedilol at different doses on cardiac myocyte apoptosis and apoptosis-associated gene in rats with pressure overload
下载PDF
导出
摘要 目的 :探讨不同剂量卡维地络 (CAR)对压力超负荷心肌肥厚幼鼠心肌细胞凋亡的影响 ,以及CAR治疗充血性心力衰竭 (CHF)的作用机制。方法 :建立腹主动脉狭窄所致压力负荷增加心肌肥厚幼鼠模型 ,术后 1周开始给予小剂量CAR(0 .1mg·kg-1·d-1)和大剂量CAR(10mg·kg-1·d-1)干预 7周 ,观察不同剂量CAR对幼鼠血流动力学参数、心肌细胞凋亡、Bcl 2和P5 3蛋白水平表达的影响。结果 :CAR可改善心功能指标 ,降低心肌细胞凋亡指数、上调Bcl 2蛋白及下调P5 3蛋白表达 ,HCAR组作用明显。结论 :CAR可有效减少压力超负荷心肌肥厚幼鼠的心肌细胞凋亡 ,防治CHF ,效果以大剂量明显 。 AIM: To study the effects and mechanism of carvedilol (CAR) at different doses on cardiac myocyte apoptosis in rats with myocardial hypertrophy of CHF. METHODS: Using the animal model of CHF, induced by abdominal aortic constriction in male Wistar rats, hemodyanmics parameters, cardiac myocyte apoptosis, and the expression of Bcl-2 and P53 were investigated in the untreated experimental group (CHF group) at 1 week after operation and treated experimental groups in which rats were treated with CAR at a lower dose (LCAR group, 0.1 mg·kg -1·d -1) and at a higher dose (HCAR group, 10 mg·kg -1·d -1) for 7 weeks since 1 week after operation. The sham-operated rats were as controls (SH group, n=8). RESULTS: Either doses improved heart function and decreased apoptosis index in rats with CHF. The number of myocytes apoptosis and the level of Bcl-2 were significantly higher and P53 was markedly lower in HCAR group than those in LCAR and MCAR groups. CONCLUSION: CAR can effectively decrease myocardiocyte apoptosis, prevent and cure CHF. The effects are dose-dependent, associated with changes of the expression of apoptosis-associated gene.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第7期824-827,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 心力衰竭 充血性心力衰竭 卡维地络 幼鼠 细胞凋亡 基因 heart failure congestive carvedilol apoptosis gene rats
  • 相关文献

参考文献7

  • 1[1]Versa P,Hagopian M,Loud AV.Quantitative localization radio autographic of protein synthesis in experimental cardiac hypertrophy[J].Lab Invest,1973;29(3):282-92
  • 2[2]Capomolla S,Febo O,Gnemmi M,Riccardi G,Opasich C,Caporotondi A,et al.β-blockade therapy in chronic heart failure:diastolic function and mitral regurgitation improvement by carvedilol[J].Am Heart J,2000;139(4):596-608
  • 3[3]Cohn JN,Ferrari R,Sharpe N.Cardiac remodeling concepts and clinical implications:a consensus paper from an international forum on cardiac remodeling[J].J Am Coll Cardiol,2000;35(3):569-82
  • 4[4]Olivetti G,Abbi R,Quaini F,Kajstura J,Cheng W,Nitahara JA,et al.Apoptosis in the failing human heart[J].N Eng J Med,1996;336(16):1131-41
  • 5[5]Li Z,Bing OHL,Long X,Robinson KG,Lakatta EG.Increased cardiomyocyte apoptosis during the transition of heart failure in the spontaneously hypertensiverat[J].Am J Physiol,1997;272(5 Pt 2):H2313-9
  • 6[6]Obert TS,Enrino M.Fifth Annual Pezcoller Symposium:Apoptosis[J].Cancer Res,1994;54(1):302-5
  • 7[7]Krishenbaum LA,Msc DM.The Bcl-2 gene product prevents programmed cell death of rentricular myocytes[J].Circulation,1997;96(15):1580-5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部